Top Markets
Coin of the day
DiaSorin S.p.A. DiaSorin S.p.A.

DiaSorin S.p.A.

DIA
Rank in Stocks #3923
DiaSorin S.p.A. engages in research and development, manufacture, and... DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.
Share Price
$89.96
Market Cap
$4.45B
Change (1 day)
-0.16%
Change (1 year)
-14.59%
Country
IT
Trade DiaSorin S.p.A. (DIA)

Category

P/B ratio for DiaSorin S.p.A. (DIA)
P/B ratio as of 2026 TTM: 0
According to DiaSorin S.p.A. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for DiaSorin S.p.A. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
4.1431 -
US
2.7156 -
US
- -
CN
24.3791 -
US
5.9029 -
US